Supernus Pharmaceuticals | Lånekapital



Loan Capital Ändra Datum
Abbott USD 12.62B 200M 2024-12
ANI Pharmaceuticals USD 614.92M 302M 2024-12
Aurora Cannabis CAD 41.68M 542K 2024-12
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Canopy Growth CAD 467.93M 34.44M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Eisai JPY 99.82B 9M 2024-12
Eli Lilly USD 28.53B 518.3M 2024-12
Indivior 270M 2M 2024-09
Novo Nordisk 51.45B 156M 2024-09
Pacira USD 383.54M 2.35M 2024-12
Perrigo USD 3.58B 730.9M 2024-12
Pfizer USD 57.4B 597M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
United Therapeutics USD 0 0 2024-12
Xeris Pharmaceuticals USD 216.23M 14.25M 2024-09



Supernus Pharmaceuticals Lånekapital - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.